Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation
Jonathan P. Piccini(Clinical Research Institute), Robert M. Califf(Duke University), Graeme J. Hankey, Daniel E. Singer(Massachusetts General Hospital), Alan S. Go(Kaiser Permanente), Günter Breithardt(University Hospital Münster), Kenneth W. Mahaffey(Cardiovascular Institute of the South), Keith A.A. Fox(University of Edinburgh), Susanna R. Stevens(Mayo Clinic), Yuchiao Chang(Harvard University), Christopher C. Nessel(Johnson & Johnson (United States)), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Yuliya Lokhnygina(Clinical Research Institute), Richard C. Becker(University of Cincinnati), Werner Hacke(Heidelberg University), Manesh R. Patel(Duke University)
Cited by 499
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k